Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
Are there any recommendations for restarting JAKi after a provoked DVT?
Related Questions
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
Do you avoid the use of TNF inhibitors in patients with RA-ILD?
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
What is your guideline for perioperative management in RA patients on biologics undergoing spinal fusion surgery?
Do you have experience combining tocilizumab with mycophenolate in patients with scleroderma lung disease and inflammatory arthritis?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
Does the presence of bronchiectasis change your approach to a patient with otherwise well-controlled patient with RA?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
Do you combine methotrexate and leflunomide for the treatment of RA?
When considering biologic therapy after failure of MTX or triple therapy, do you consider using Abatacept as a first line biologic?
